Bright Minds Biosciences DRUG Cash Flow Statement (2019-2026)

NASDAQ DRUG
$49.82 +0.08 (+0.16%)
At close: Sep 30, 2026 · 4:00 PM EDT
Reported Financials

Bright Minds Biosciences Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

Bright Minds Biosciences reported cash from operations of -$6.03M and free cash flow of -$6.03M for the quarter ended Jun 2026, down 338.4% year over year. This cash flow statement covers 25 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
2.28M3.85M3.54M2.09M2.27M1.72M1.52M1.09M-9.86M-1.24M2.93M-0.17M-3.54M0.03M2.35M3.78M-14.80M-6.01M20.77M-1.73M
Share-based Compensation
0.30M0.21M0.23M0.23M0.02M0.36M0.02M0.18M0.30M0.16M0.17M0.13M0.15M0.13M0.43M0.95M0.78M0.92M0.88M1.12M
Cash from Operations
1.90M3.93M2.88M2.24M1.63M1.96M1.12M1.23M-9.59M0.60M0.60M-0.18M-2.37M1.07M1.69M2.53M-11.71M-4.17M-6.74M-6.03M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.01M0.01M0.01M0.01M0.01M0.01M-0.02M0.05M0.02M0.02M0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Receivables
0.15M-0.03M-0.02M0.09M-0.04M0.04M0.02M-0.05M0.02M0.01M0.01M-0.00M-0.01M0.03M-0.03M0.05M-0.19M-0.04M0.08M-0.05M
Change in Account Payables
Change in Accured Expenses
0.26M0.12M0.17M-0.09M0.39M-0.70M0.35M0.92M-1.46M0.44M0.01M-0.47M0.21M-0.04M0.12M-0.02M1.17M-0.47M1.66M-0.92M
Investing Activities
Cash from Investing Activities
Financing Activities
Other financing activities
0.46M-0.02M0.06M-0.32M-0.38M-10.79M
Change in Capital Stock
Net Equity Issued and Repurchased
0.09M-0.07M1.24M0.19M-0.19M0.67M0.17M0.01M0.11M0.01M0.03M0.08M
Misc.
Cash from Financing Activities
-0.01M0.09M0.00M0.01M3.88M1.66M-0.02M-0.02M-0.02M0.64M-0.02M-0.02M-0.02M37.25M0.16M-0.01M24.21M9.60M166.60M0.06M
Exchange Rate Effect
0.12M0.15M-0.01M0.02M0.04M0.01M0.00M0.08M-0.12M-0.03M-0.00M0.03M0.01M1.17M-0.01M-0.56M-0.38M-1.03M1.04M4.62M
Change in Cash
-1.91M3.83M2.88M2.24M-2.25M-0.30M1.74M1.24M-6.30M0.04M-0.61M0.16M-0.36M36.18M-1.53M-2.54M23.29M5.43M159.86M-5.97M
Beginning Cash Balance
15.68M8.57M4.96M4.09M59.45M
Free Cash Flow
1.90M3.93M2.88M2.24M1.63M1.96M1.12M1.23M-9.59M0.60M0.60M-0.18M-2.37M1.07M1.69M2.53M-11.71M-4.17M-6.74M-6.03M
Net Cash Flow
1.89M4.02M2.88M2.25M5.52M3.62M1.10M1.21M-9.60M1.25M0.58M-0.19M-2.39M38.32M1.85M2.52M12.50M5.43M159.86M-5.97M

Bright Minds Biosciences Cash Flow Statement API

Pull Bright Minds Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DRUG&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY